Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Spiekermann

Showing results (21-30 of 202) with videos related to

Pageof 21
Sort By:
Experimental Hematology|March 8, 2002
Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cellsKarsten Spiekermann, Michael Pau, Ruth Schwab, et al.
Deutsche Medizinische Wochenschrift (1946)|July 13, 2021
[Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology]Karsten Spiekermann, Marion Subklewe, Martin Hildebrandt, et al.
Annals of Hematology|June 10, 2023
Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcomeAlessia Fraccaroli, Daniela Vogt, Margarete Rothmayer, et al.
Deutsche Medizinische Wochenschrift (1946)|August 28, 2022
[Acute Myeloid Leukemia - Update 2022]Christian Rausch, Wolfgang Hiddemann, Michael von Bergwelt-Baildon, et al.
Blood|December 25, 2004
KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factorTobias M Kohl, Susanne Schnittger, Joachim W Ellwart, et al.
Deutsche Medizinische Wochenschrift (1946)|July 31, 2020
[COVID-19 from the Perspective of Haematology and Haemostaseology]Karsten Spiekermann, Marion Subklewe, Martin Hildebrandt, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2007
[Therapy of acute myeloid leukemia (AML) for medically non-fit patients]Susanne Fritsch, Christian Buske, Bernhard Wörmann, et al.
Plos One|April 19, 2019
Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysisAnne-Sophie Sandner, Ramona Weggel, Yasmin Mehraein, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2007
[Diagnostics, classification and prognostic criteria of acute myeloid leukemia]Bernhard Heilmeier, Christian Buske, Karsten Spiekermann, et al.
Blood|October 29, 2005
KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survivalSusanne Schnittger, Tobias M Kohl, Torsten Haferlach, et al.
Pageof 21

Showing results (21-30 of 202) with videos related to

Sort By:
Pageof 21
Experimental Hematology|March 8, 2002
Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cellsKarsten Spiekermann, Michael Pau, Ruth Schwab, et al.
Deutsche Medizinische Wochenschrift (1946)|July 13, 2021
[Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology]Karsten Spiekermann, Marion Subklewe, Martin Hildebrandt, et al.
Annals of Hematology|June 10, 2023
Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcomeAlessia Fraccaroli, Daniela Vogt, Margarete Rothmayer, et al.
Deutsche Medizinische Wochenschrift (1946)|August 28, 2022
[Acute Myeloid Leukemia - Update 2022]Christian Rausch, Wolfgang Hiddemann, Michael von Bergwelt-Baildon, et al.
Blood|December 25, 2004
KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factorTobias M Kohl, Susanne Schnittger, Joachim W Ellwart, et al.
Deutsche Medizinische Wochenschrift (1946)|July 31, 2020
[COVID-19 from the Perspective of Haematology and Haemostaseology]Karsten Spiekermann, Marion Subklewe, Martin Hildebrandt, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2007
[Therapy of acute myeloid leukemia (AML) for medically non-fit patients]Susanne Fritsch, Christian Buske, Bernhard Wörmann, et al.
Plos One|April 19, 2019
Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysisAnne-Sophie Sandner, Ramona Weggel, Yasmin Mehraein, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2007
[Diagnostics, classification and prognostic criteria of acute myeloid leukemia]Bernhard Heilmeier, Christian Buske, Karsten Spiekermann, et al.
Blood|October 29, 2005
KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survivalSusanne Schnittger, Tobias M Kohl, Torsten Haferlach, et al.
Pageof 21